RSS Feeds
Search

Press releases

Press releases

Displaying 1..1 of 1 - per page
Order by
Desitin and G2M Cancer Drugs sign development agreement on novel cancer treatment
G2M Cancer Drugs AG and Desitin Arzneimittel GmbH announced today that they have entered into an agreement to develop an innovative formulation for the histone deacetylase (HDAC) inhibitor G2M-777 for cancer treatment. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Liver Cancer - Pipeline Review, Q3 2011
Jul 2011 - 200 pages - $500
Metastatic Liver Cancer - Pipeline Review, Q3 2011
Jul 2011 - 143 pages - $500
Liver Cancer Therapy Area Pipeline Report
Nov 2010 - 500 pages - $1,495
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Metastatic Liver Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010 - 66 pages - $1,000
Liver Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 49 pages - $2,000
ZIOPHARM Oncology Inc: Corporate and Strategic Assessment Report – Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile
Jun 2008 - 40 pages - $495
Liver Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010 - 75 pages - $1,000
Metastatic Liver Cancer - Pipeline Review, Q1 2011
Jan 2011 - 54 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us